Interleukin Inhibitors Market
According to Intent Market Research, the Interleukin Inhibitors Market is expected to grow from USD 17.2 Billion in 2024-e at a CAGR of 11.5% to touch USD 33.0 Billion by 2030. The Interleukin Inhibitors Market is dominated by key players such as Janssen Biotech, Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., Eli Lilly and Co., Amgen Inc., and Sanofi S.A.